Antibiotic administration shortly before or after immunotherapy initiation is correlated with poor prognosis in solid cancer patients: An up-to-date systematic review and meta-analysis-Reference-Cited by-同舟云学术

Antibiotic administration shortly before or after immunotherapy initiation is correlated with poor prognosis in solid cancer patients: An up-to-date systematic review and meta-analysis

Published:2020-11 Issue: Volume:88 Page:106876
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Yang Mengxue,Wang Ying,Yuan Man,Tao Mingyang,Kong Cheng,Li Hao,Tong Jiandong,Zhu Huiyuan,Yan Xuebing

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference58 articles.

1. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018

2. Top 10 challenges in cancer immunotherapy;Hegde;Immunity,2020

3. Gut microbiome as a potential factor for modulating resistance to cancer immunotherapy;Shui;Front. Immunol,2020

4. The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy;Gopalakrishnan;Cancer Cell,2018

5. Gut microbiome: a promising biomarker for immunotherapy in colorectal cancer;Temraz;Int. J. Mol. Sci.,2019

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of metformin in solid cancer patients receiving immune checkpoint inhibitors: novel evidences from a multicenter retrospective study;Frontiers in Pharmacology;2024-07-29

2. Antibiotic use during radical surgery in stage I-III colorectal cancer: correlation with outcomes?;BMC Cancer;2024-06-26

3. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data;Journal of Cancer Research and Clinical Oncology;2024-04-10

4. A novel investigation into the negative impact of opioid use on the efficacy of immune checkpoint inhibitors in advanced non-small cell lung cancer patients;International Immunopharmacology;2024-03

5. Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: Analysis of Health Insurance Review and Assessment data;2024-02-12